Financhill
Buy
55

JPM Quote, Financials, Valuation and Earnings

Last price:
$302.50
Seasonality move :
2.48%
Day range:
$296.52 - $304.29
52-week range:
$202.16 - $337.25
Dividend yield:
1.92%
P/E ratio:
15.12x
P/S ratio:
3.01x
P/B ratio:
2.38x
Volume:
9.1M
Avg. volume:
11.9M
1-year change:
9.49%
Market cap:
$815.7B
Revenue:
$280.3B
EPS (TTM):
$20.01

Earnings Data

Next earnings date for JPM
Apr 14
2026
Most recent earnings per share
$4.63
Missed by $0.19
(Jan 13/2026)
Consensus Estimate
$4.82
(Jan 13/2026)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JPM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/14/2026 Q1 $48.1B -- -- $5.32 --
01/13/2026 Q4 $46.2B $69.6B $4.63 $4.82 -$0.19
10/14/2025 Q3 $45.6B $71.7B $5.07 $4.87 $0.20
07/15/2025 Q2 $44B $69.8B $5.24 $4.47 $0.76
04/11/2025 Q1 $44.1B $68.7B $5.07 $4.64 $0.42
01/15/2025 Q4 $41.6B $67.5B $4.81 $4.04 $0.77
10/11/2024 Q3 $41.4B $69.2B $4.37 $3.99 $0.39
07/12/2024 Q2 $46.2B $75.9B $6.12 $4.53 $1.59
04/12/2024 Q1 $41.7B $66.5B $4.44 $4.13 $0.31
01/12/2024 Q4 -- $63B $3.04 -- --
10/13/2023 Q3 -- $62.2B $4.33 -- --
07/14/2023 Q2 -- $61.3B $4.75 -- --
04/14/2023 Q1 -- $56.3B $4.10 -- --
01/13/2023 Q4 -- $47.2B $3.57 -- --
10/14/2022 Q3 -- $41.2B $3.12 -- --
07/14/2022 Q2 -- $35.3B $2.76 -- --
04/13/2022 Q1 -- $33.3B $2.63 -- --
01/14/2022 Q4 -- $29B $3.33 -- --
10/13/2021 Q3 -- $31.4B $3.74 -- --
07/13/2021 Q2 -- $31.8B $3.78 -- --
04/14/2021 Q1 -- $34.8B $4.50 -- --
01/15/2021 Q4 -- $30.8B $3.79 -- --
10/13/2020 Q3 -- $31.2B $2.92 -- --
07/14/2020 Q2 -- $35.4B $1.38 -- --
04/14/2020 Q1 -- $32B $0.78 -- --
01/14/2020 Q4 -- $34.4B $2.57 -- --
10/15/2019 Q3 -- $35.7B $2.68 -- --
07/16/2019 Q2 -- $35.5B $2.82 -- --
04/12/2019 Q1 -- $35.7B $2.65 -- --
01/15/2019 Q4 -- $32.5B $1.98 -- --
10/12/2018 Q3 -- $33.4B $2.34 -- --
07/13/2018 Q2 -- $33.3B $2.29 -- --
04/13/2018 Q1 -- $32.7B $2.37 -- --
01/12/2018 Q4 -- $29.1B $1.08 -- --
10/12/2017 Q3 -- $29.5B $1.76 -- --
07/14/2017 Q2 -- $29.1B $1.82 -- --
04/13/2017 Q1 -- $28.1B $1.65 -- --
01/13/2017 Q4 -- $27.3B $1.71 -- --
10/14/2016 Q3 -- $27.1B $1.58 -- --
07/14/2016 Q2 -- $26.3B $1.55 -- --
04/13/2016 Q1 -- $24.6B $1.35 -- --

JPMorgan Chase & Co. Earnings Questions

  • How Much did JPMorgan Chase & Co. Generate in Revenue Last Quarter?

    JPMorgan Chase & Co. reported $69.6B worth of top line sales in its most recent quarter.

  • Did JPMorgan Chase & Co. Beat Earnings Last Quarter?

    JPMorgan Chase & Co. announced earnings per share of $4.63 which represents a miss of analyst forecast a $4.82 per share.

  • Is JPMorgan Chase & Co. Profitable?

    JPMorgan Chase & Co. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for JPMorgan Chase & Co. EPS Next Year?

    JPMorgan Chase & Co.'s earnings are forecast to grow from $20.02 per share to $20.01 per share next year representing an increase of 7.53%.

  • When is JPMorgan Chase & Co.'s Earnings Date?

    JPMorgan Chase & Co.'s next earnings date is April 14, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
77
CPS alert for Feb 14

Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.

Buy
58
TPH alert for Feb 14

Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.

Sell
20
IRON alert for Feb 14

Disc Medicine, Inc. [IRON] is down 21.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock